Kawaji-Kanayama, Yuka
Muramatsu, Ayako
Sasaki, Nana
Shimura, Kazuho
Kiyota, Miki
Fuchida, Shinichi
Isa, Reiko
Fujino, Takahiro
Matsumura-Kimoto, Yayoi
Tsukamoto, Taku
Chinen, Yoshiaki
Mizutani, Shinsuke
Nakao, Mitsushige
Kaneko, Hiroto
Kawata, Eri
Hirakawa, Koichi
Takahashi, Ryoichi
Shimazaki, Chihiro
Uchiyama, Hitoji
Uoshima, Nobuhiko
Shimura, Yuji
Kobayashi, Tsutomu
Taniwaki, Masafumi
Kuroda, Junya http://orcid.org/0000-0001-6130-1550
,
Funding for this research was provided by:
Ono Pharmaceutical
Article History
Received: 1 October 2021
Revised: 12 November 2021
Accepted: 14 November 2021
First Online: 24 January 2022
Declarations
:
: This study is supported by Ono Pharmaceutical. J.K. has received research funding from Bristol-Myers Squibb, Sysmex, Ono Pharmaceutical, Sanofi, Takeda, Fujimoto Pharmaceutical, and Abbvie; has received honoraria from Bristol-Myers Squibb, Janssen Pharmaceutical K.K, Ono Pharmaceutical, Takeda, Sanofi, Fujimoto Pharmaceutical, and Abbvie; and is a consultant for Janssen Pharmaceutical K.K, and Bristol-Myers Squibb. T.K. has received honoraria from Ono Pharmaceutical. M.T. has received honoraria from Bristol-Myers Squibb. N.U. has received honoraria from Bristol-Myers Squibb and Takeda. S.F. has received honoraria from Takeda, Ono Pharmaceutical, Bristol-Myers Squibb, Sanofi, and Janssen Pharmaceutical. All other authors have no conflict of interest.